7-147879319-C-T

Variant summary

Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1

The NM_014141.6(CNTNAP2):​c.2099-24246C>T variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.57 in 151,884 control chromosomes in the GnomAD database, including 25,229 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.

Frequency

Genomes: 𝑓 0.57 ( 25229 hom., cov: 32)

Consequence

CNTNAP2
NM_014141.6 intron

Scores

2

Clinical Significance

Not reported in ClinVar

Conservation

PhyloP100: -0.378

Publications

6 publications found
Variant links:
Genes affected
CNTNAP2 (HGNC:13830): (contactin associated protein 2) This gene encodes a member of the neurexin family which functions in the vertebrate nervous system as cell adhesion molecules and receptors. This protein, like other neurexin proteins, contains epidermal growth factor repeats and laminin G domains. In addition, it includes an F5/8 type C domain, discoidin/neuropilin- and fibrinogen-like domains, thrombospondin N-terminal-like domains and a putative PDZ binding site. This protein is localized at the juxtaparanodes of myelinated axons, and mediates interactions between neurons and glia during nervous system development and is also involved in localization of potassium channels within differentiating axons. This gene encompasses almost 1.5% of chromosome 7 and is one of the largest genes in the human genome. It is directly bound and regulated by forkhead box protein P2, a transcription factor related to speech and language development. This gene has been implicated in multiple neurodevelopmental disorders, including Gilles de la Tourette syndrome, schizophrenia, epilepsy, autism, ADHD and intellectual disability. [provided by RefSeq, Jul 2017]
CNTNAP2 Gene-Disease associations (from GenCC):
  • complex neurodevelopmental disorder
    Inheritance: AD, AR Classification: DEFINITIVE, NO_KNOWN Submitted by: ClinGen
  • cortical dysplasia-focal epilepsy syndrome
    Inheritance: AR Classification: DEFINITIVE, STRONG, MODERATE, SUPPORTIVE Submitted by: G2P, Illumina, Labcorp Genetics (formerly Invitae), Orphanet, Ambry Genetics

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -12 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.85).
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.686 is higher than 0.05.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_014141.6. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
CNTNAP2
NM_014141.6
MANE Select
c.2099-24246C>T
intron
N/ANP_054860.1

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
CNTNAP2
ENST00000361727.8
TSL:1 MANE Select
c.2099-24246C>T
intron
N/AENSP00000354778.3
CNTNAP2
ENST00000455301.2
TSL:3
n.34-24246C>T
intron
N/A
CNTNAP2
ENST00000627772.2
TSL:2
n.272-24246C>T
intron
N/A

Frequencies

GnomAD3 genomes
AF:
0.570
AC:
86442
AN:
151766
Hom.:
25192
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.693
Gnomad AMI
AF:
0.357
Gnomad AMR
AF:
0.586
Gnomad ASJ
AF:
0.610
Gnomad EAS
AF:
0.613
Gnomad SAS
AF:
0.486
Gnomad FIN
AF:
0.484
Gnomad MID
AF:
0.570
Gnomad NFE
AF:
0.507
Gnomad OTH
AF:
0.602
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome
AF:
0.570
AC:
86527
AN:
151884
Hom.:
25229
Cov.:
32
AF XY:
0.567
AC XY:
42063
AN XY:
74198
show subpopulations
African (AFR)
AF:
0.693
AC:
28704
AN:
41430
American (AMR)
AF:
0.586
AC:
8938
AN:
15260
Ashkenazi Jewish (ASJ)
AF:
0.610
AC:
2116
AN:
3470
East Asian (EAS)
AF:
0.612
AC:
3148
AN:
5144
South Asian (SAS)
AF:
0.485
AC:
2329
AN:
4798
European-Finnish (FIN)
AF:
0.484
AC:
5092
AN:
10526
Middle Eastern (MID)
AF:
0.565
AC:
166
AN:
294
European-Non Finnish (NFE)
AF:
0.507
AC:
34437
AN:
67950
Other (OTH)
AF:
0.605
AC:
1273
AN:
2104
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.500
Heterozygous variant carriers
0
1835
3671
5506
7342
9177
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
730
1460
2190
2920
3650
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.511
Hom.:
6950
Bravo
AF:
0.585
Asia WGS
AF:
0.579
AC:
2015
AN:
3478

ClinVar

Not reported in ClinVar

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.85
CADD
Benign
0.068
DANN
Benign
0.64
PhyloP100
-0.38
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs1922892; hg19: chr7-147576411; API